Symptomatic: A New Era of Chronic Pain and Illness Treatment
PORTLAND, OR, October 29, 2024 /24-7PressRelease/ -- The Psychophysiologic Disorders Association (PPDA) is proud to announce its rebranding as the Association for Treatment of Neuroplastic Symptoms (ATNS) under the new brand and social banner of Symptomatic. This transformation comes with a renewed focus on staying at the forefront of scientific advancements in treating chronic pain and illness, offering an evidence-based approach to millions worldwide affected by neuroplastic symptoms. The organization's new website can be found at Symptomatic.Me.
Neuroplasticity — the brain's ability to adapt, change, and heal — lies at the heart of the group's mission. The mission remains educating practitioners and patients about neuroplastic symptoms, which are generated by the brain in response to past or present stress. These symptoms include chronic primary pain, migraines, fibromyalgia, irritable bowel syndrome, post-viral syndromes, and many other conditions. The name change reflects the association's growth and commitment to empowering people to understand and overcome these symptoms with the newest science.
David D. Clarke, MD, President of ATNS, said, "Our mission has always been to ensure people receive the right kind of care. Too often, patients are treated for symptoms without considering the underlying neuroplastic causes — leading to ineffective outcomes. We are here to change that narrative. Everyone deserves the best care, focusing on healing rather than just living with symptoms. This rebranding makes our mission more widely approachable and understandable for both the public and practitioners, helping us bridge the gap between research results and effective clinical care."
An estimated 1.5 billion people worldwide suffer from chronic pain or illness that is not caused by disease or injury. Four out of ten people seen by physicians suffer from these neuroplastic conditions. What if their symptoms could be permanently relieved with the proper care? ATNS is the leader in sharing the new science for treating these conditions, because a life without pain and illness is possible.
Through its mission of sharing the new science of chronic pain and illness, ATNS goals include:
• Educate the Public
• Advance Scientific Research
• Empower Practitioners
• Support Patients
• Collaborate Across Disciplines
• Advocate for Policy Change
Howard Schubiner, MD, ATNS board member and Clinical Professor at Michigan State University, stated, "The understanding of neuroplastic symptoms represents a significant leap in the medical community's approach to chronic pain. By recognizing that the brain can generate pain in response to stress rather than structural issues, we can provide more accurate diagnoses and effective treatments. This shift is not just about managing symptoms — it's about offering real, sustainable healing options to patients who have long struggled with unexplained pain or illness."
The launch marks an exciting opportunity to grow the robust community committed to sharing the latest science and education in treating chronic pain correctly.
Rebecca Kennedy, MD, board member and Family Medicine Physician, also expressed her excitement: "Our focus on neuroplastic symptoms brings hope for more effective, compassionate care for those who need it most. This new chapter is about growth, empowerment, and transformation — not just for our organization, but for the countless individuals we serve."
"We invite medical professionals, patients, researchers, the public, and advocates to join us in this journey as we continue transforming the understanding and treatment of neuroplastic symptoms," remarked Clarke.
About Dr. David Clarke: David Clarke MD is the President of the Association for Treatment of Neuroplastic Symptoms (ATNS), a 501(c)(3) nonprofit dedicated to ending the chronic pain epidemic. Dr. Clarke holds an MD from the University of Connecticut School of Medicine, and is Board-certified in Internal Medicine and Gastroenterology. His organization's mission is to advance the awareness, diagnosis, and treatment of stress-related, brain-generated medical conditions. Learn more at Symptomatic.Me.
About SYMPTOMATIC: Association for Treatment of Neuroplastic Symptoms
The Association for Treatment of Neuroplastic Symptoms (ATNS) is a 501(c)(3) nonprofit founded in 2011. Our mission is to share the latest scientific evidence about successful diagnosis and treatment of neuroplastic symptoms. These are generated by the brain, link to past or present stress, and include chronic primary pain (in any location), migraine, fibromyalgia, irritable bowel, bladder spasm, fatigue, post-viral syndromes, and many more. Millions are affected, but by sharing the Pain Relief Psychology used with great benefit in the latest research trials, the association empowers patients and practitioners with knowledge that becomes healing. Learn more at Symptomatic.Me, and visit the Association on social media at @Symptomatic.Me on Instagram, Facebook, YouTube, TikTok, and LinkedIn. #SymptomaticMe
Online press kit: davidclarke.onlinepresskit247.com
For more information or interview requests, contact Executive Publicist Michelle Tennant Nicholson at Michelle@WasabiPublicity.com or 828-749-3200.
---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
